Page last updated: 2024-09-02

6-methyl-1,3,8-trichlorodibenzofuran and Cancer of Liver

6-methyl-1,3,8-trichlorodibenzofuran has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fretland, AJ; Hankinson, O; Safe, S1

Other Studies

1 other study(ies) available for 6-methyl-1,3,8-trichlorodibenzofuran and Cancer of Liver

ArticleYear
Lack of antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin's (TCDDs) induction of cytochrome P4501A1 (CYP1A1) by the putative selective aryl hydrocarbon receptor modulator 6-alkyl-1,3,8-trichlorodibenzofuran (6-MCDF) in the mouse hepatoma cell line Hepa-1c
    Chemico-biological interactions, 2004, Nov-20, Volume: 150, Issue:2

    Topics: Animals; Benzofurans; Carcinoma, Hepatocellular; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Liver Neoplasms; Mice; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; RNA, Messenger

2004